Sanofi to acquire BTK inhibitor firm Principia for $3.7 billion
Tuesday, August 18, 2020 - 09:31
in Health & Medicine
Principia is testing its small-molecule compounds in multiple sclerosis and immune system diseases
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via